Loading...
NPI 1356657787 · Oradell, NJ · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Sovereign Laboratory Services, LLC is a clinical medical laboratory provider located in Oradell, New Jersey. This profile covers 25 Medicare and 34 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Sovereign Laboratory Services, LLC |
| Address | 680 Kinderkamack Rd Ste 101b |
| City | Oradell |
| State | NJ |
| ZIP | 07649 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | August 23, 2010 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $1.5M |
| Medicare | $641.8K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
25 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 10,220 | $30 | $347.4K |
| 81185 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the calcium voltage–gated channel subunit alpha1 A gene, also called CACNA1A. | 40 | $770 | $28.6K |
| 81249 | The lab analyst performs the technical lab test to analyze known the full gene sequence of the glucose–6–phosphate dehydrogenase (G6PD) gene. | 70 | $420 | $27.5K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 790 | $30 | $26.7K |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 790 | $30 | $26.7K |
| 81317 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the postmeiotic segregation increased 2 [S. cerevisiae], or PMS2 gene. | 40 | $650 | $25.4K |
| 81201 | The lab analyst performs the technical lab test to analyze the entire gene sequence for adenomatous polyposis coli, also known as APC. | 30 | $760 | $22.2K |
| 81226 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily D, polypeptide 6, also known as CYP2D6. | 40 | $440 | $19.4K |
| 81298 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the mutS homolog 6 [E. coli], or MSH6 gene. | 30 | $610 | $17.7K |
| 81223 | The lab analyst performs the technical lab test to analyze the entire gene sequence for cystic fibrosis transmembrane conductance regulator gene, also known as CFTR. | 40 | $490 | $17.6K |
Showing 1–10 of 25
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
25 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81185 | 2 | 10 | 890 | $830 | $734.4K |
| 81249 | 5 | 10 | 830 | $590 | $692.2K |
| 81317 | 6 | 10 | 60 | $660 | $511.5K |
| 81298 | 6 | 10 | 60 | $630 | $489.5K |
| 81223 | 5 | 10 | 830 | $490 | $467.8K |
| 87798 | 9 | 40 | 1,760 | $30 | $284.3K |
| 81201 | 4 | 10 | 30 | $760 | $193.4K |
| 81226 | 6 | 10 | 50 | $440 | $133.4K |
| 81295 | 6 | 10 | 170 | $370 | $108.6K |
| U0003 | 36 | 80 | 110 | $70 | $101.7K |
Showing 1–10 of 25
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
34 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 12,860 | $70 | $861.4K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 3,450 | $90 | $293.4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 10,750 | $20 | $236.5K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 12,180 | $10 | $97.5K |
| 87811 | The lab analyst performs the technical lab test to analyze for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) (Coronavirus disease [COVID–19]) in a specimen by… | 220 | $40 | $8.2K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 2,810 | $1 | $5.6K |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 2,820 | $1 | $2.8K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 30 | $20 | $560 |
| 84153 | The lab analyst performs testing for total prostate specific antigen, PSA, typically on serum or plasma samples using laboratory analyzers. PSA is a protein the prostate gland produces, and… | 550 | $1 | $550 |
| 84403 | The lab analyst performs a test to measure total testosterone, typically in patient serum. | 540 | $1 | $540 |
Showing 1–10 of 34
How this provider's Medicaid billing volume and revenue compare to other New Jersey providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New Jersey median
34 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 41 | 130 | 3,180 | $60 | $4.2M |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 110 | 120 | 900 | $20 | $971.9K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 107 | 120 | 940 | $20 | $957.4K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 41 | 50 | 400 | $10 | $839.8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 53 | 140 | 5,590 | $20 | $823.1K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 17 | 90 | 630 | $30 | $806.2K |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 40 | 50 | 300 | $20 | $629.9K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 75 | 140 | 870 | $10 | $605.2K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 9 | 40 | 390 | $20 | $564.3K |
| 81408 | The lab analyst performs the technical lab test to complete one of the specific genetic analyses listed in this Tier 2, Level 9 molecular pathology code. | 5 | 10 | 50 | $710 | $555.2K |
Showing 1–10 of 34
Other providers in the same ZIP code as Sovereign Laboratory Services, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Sovereign Medical Group LLC | NJ | Urology Physician | $0 | $8.3M |
| Surgicare Surgical Associates Of Oradell, LLC | NJ | Ambulatory Surgical Clinic/Center | $488.8K | $256.9K |
| Andrew Prince | NJ | Ophthalmology Physician | $391.2K | $1.2K |
| Vincent Giacalone | NJ | Foot & Ankle Surgery Podiatrist | $161.5K | $0 |
| Fiona Gupta | NJ | Neurology Physician | $148.9K | $300 |
| Cristina Saiz Rodriguez | NJ | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician | $117.7K | $0 |
| Jay Rosen | NJ | Urology Physician | $115.7K | $0 |
| Hooman Azmi-ghadimi | NJ | Neurological Surgery Physician | $97.7K | $0 |
| Daniel Wilkin | NJ | Family Medicine Physician | $90.5K | $0 |
| Giorgio Rotoli | NJ | Neurological Surgery Physician | $80.9K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.